{"title":"Severe hyponatremia following low-dose cyclophosphamide in a patient with breast cancer: a case report.","authors":"Çiğdem Cindoğlu, Fatma Zehra Ağan","doi":"10.1007/s13691-026-00908-9","DOIUrl":"10.1007/s13691-026-00908-9","url":null,"abstract":"<p><p>Cyclophosphamide is a commonly used alkylating chemotherapy agent in the treatment of neoadjuvant, adjuvant, and metastatic breast cancer. Sudden onset, symptomatic, and severe hyponatremia (defined as serum sodium < 125 mmol/L) is a rare but potentially life-threatening complication associated with cyclophosphamide use. We report a case of severe acute hyponatremia in a 47-year-old female patient diagnosed with invasive ductal breast carcinoma. The patient received low-dose cyclophosphamide as part of adjuvant chemotherapy and experienced generalized tonic-clonic seizures within the first 24 h. Laboratory investigations revealed severe hyponatremia with a serum sodium level of 111 mmol/L. Neurological imaging and endocrine evaluations ruled out alternative causes. Cyclophosphamide-induced SIADH was considered the most likely cause of the patient's severe hyponatremia. Hypertonic saline therapy was initiated, leading to rapid normalization of serum sodium levels and complete resolution of neurological symptoms. Following discontinuation of thiazide-containing antihypertensive therapy, subsequent chemotherapy courses were completed without recurrence of hyponatremia. This case highlights the potential for life-threatening hyponatremia even with low-dose cyclophosphamide use and underscores the critical importance of early electrolyte monitoring, particularly in patients receiving concomitant diuretics.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"15 4","pages":"608-611"},"PeriodicalIF":0.4,"publicationDate":"2026-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13597999/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149038477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A case of pelvic irradiation field-associated metachronous multiple primary cancer: cancer of unknown primary suspected to originate from the colon 18 years after treatment for cervical cancer.","authors":"Yusuke Motomura, Yu Aoki, Shinsuke Funakoshi, Toshio Ohashi","doi":"10.1007/s13691-026-00902-1","DOIUrl":"10.1007/s13691-026-00902-1","url":null,"abstract":"<p><p>A woman in her 50 s presented with invasive mucinous adenocarcinoma of unknown primary origin 18 years after undergoing radical hysterectomy and two-dimensional chemoradiotherapy for FIGO stage IB1 cervical cancer. Over two decades, the patient developed chronic radiation-induced complications, including pelvic abscesses, enterocutaneous fistulas, and progressive renal impairment. These chronic changes formed a 'pelvic cocoon' that masked the development of a secondary malignancy. Diagnosis was achieved through random biopsies of the fistula site, whilst repeated endoscopies were negative. Management required complex decision-making, resulting in the selection of a modified 'folinic acid, fluorouracil, and irinotecan' regimen due to severe renal dysfunction (creatinine clearance < 20 mL/min) and UGT1A1*28/*28 homozygosity, adhering to stringent European safety standards. This case illustrates delayed recognition of secondary malignancy arising from chronic inflammatory and post-treatment changes, emphasising the need for a high index of clinical suspicion and individualised therapeutic strategies in long-term cancer survivors.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at https://doi.org/10.1007/s13691-026-00902-1.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"15 4","pages":"556-567"},"PeriodicalIF":0.4,"publicationDate":"2026-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13597971/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149037826","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A case of severe enteritis following CapeOX therapy in a postoperative rectal cancer patient with m.3243A>G-associated mitochondrial disease.","authors":"Hyuga Kawakubo, Shunjin Ryu, Yuta Imaizumi, Daiki Suzuki, Shunsuke Nakashima, Keisuke Goto, Teppei Kamada, Atsuko Okamoto, Yasunobu Kobayashi, Yasuhiro Takano, Yasuhiro Takeda, Ryusuke Ito, Ken Eto, Kensei Yamaguchi","doi":"10.1007/s13691-026-00901-2","DOIUrl":"10.1007/s13691-026-00901-2","url":null,"abstract":"<p><p>Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) syndrome is a rare mitochondrial disorder characterized by impaired oxidative phosphorylation and reduced ATP production, resulting in increased organ vulnerability to metabolic stress. Fluoropyrimidine agents, such as 5-fluorouracil (5-FU), are widely used to treat colorectal cancer and can induce gastrointestinal toxicity not only through inhibition of thymidylate synthase and suppression of nucleic acid synthesis but also via RNA misincorporation, translational defects, and mitochondrial dysfunction in intestinal epithelial cells. The coexistence of metabolic vulnerability associated with m.3243A>G-related mitochondrial dysfunction and drug-induced mitochondrial injury may synergistically exacerbate intestinal toxicity, potentially leading to severe enteritis. A 40-year-old woman with m.3243A>G-associated mitochondrial disease within the MELAS spectrum underwent radical resection for perforated rectal cancer with synchronous liver metastases. Her postoperative course was uneventful, and she was discharged without complications. CapeOX therapy (capecitabine plus oxaliplatin) was initiated as adjuvant chemotherapy. Ten days after the start of the third cycle, she developed intermittent fever, abdominal distension, and diarrhea. Computed tomography revealed diffuse edema throughout the small intestine with massive ascites. Malignant peritonitis was considered unlikely based on imaging, ascites analysis, and cytology, whereas infectious enteritis was not strongly suspected based on the clinical course. Chemotherapy-induced enteritis associated with CapeOX was therefore strongly suspected, and the regimen was discontinued. The gastrointestinal symptoms improved, and tumor marker levels normalized. This case suggests that underlying mitochondrial dysfunction may enhance fluoropyrimidine-related intestinal toxicity, indicating that careful risk assessment and close monitoring are required when administering chemotherapy to patients with underlying mitochondrial disorders.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"15 4","pages":"568-574"},"PeriodicalIF":0.4,"publicationDate":"2026-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13598003/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149037796","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cytokine release syndrome during ipilimumab and nivolumab therapy for renal-cell carcinoma successfully treated with tocilizumab: A case report.","authors":"Ryo Nakagawa, Yushiro Takeuchi, Goshi Kitano, Makoto Kawase, Hiroki Hirabayashi, Yutaka Fujiwara, Takahiro Kojima","doi":"10.1007/s13691-026-00900-3","DOIUrl":"10.1007/s13691-026-00900-3","url":null,"abstract":"<p><p>Cytokine release syndrome is a rare and potentially fatal condition in which an abnormal immune response to various stimuli leads to a cytokine storm. However, the clinical features, optimal diagnostic approach, and predictors of the severity of immune checkpoint inhibitor-associated cytokine release syndrome remain poorly defined. Herein, we report the case of a 58-year-old Japanese man who was referred to our department with right renal-cell carcinoma with bone metastases (ilium and lumbar spine). After radiotherapy for the bone metastases, right nephrectomy was performed, and combination therapy with ipilimumab and nivolumab was initiated. The day of the first administration of ipilimumab and nivolumab was defined as day 1. After the second course, skin rash and liver dysfunction developed, and corticosteroid therapy was initiated on day 52. However, the skin rash worsened on day 65; the patient was clinically diagnosed with toxic epidermal necrolysis, and steroid pulse therapy was administered. On day 66, fever and worsening oxygenation developed, and the patient was diagnosed with cytokine release syndrome, for which tocilizumab was administered. The symptoms gradually improved and the patient was discharged on day 93. Cytokine release syndrome is a life-threatening complication characterized by progressive organ toxicity that requires prompt diagnosis and treatment. When corticosteroid therapy is insufficient, tocilizumab, an anti-interleukin 6 receptor antibody, should be considered.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"15 4","pages":"582-586"},"PeriodicalIF":0.4,"publicationDate":"2026-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13597981/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149038250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Small intestinal gastrointestinal stromal tumor with ossification presenting as a pelvic adnexal mass: a case report and literature review.","authors":"Jing Wang, Shihong Li, Guangwu Lin","doi":"10.1007/s13691-026-00899-7","DOIUrl":"10.1007/s13691-026-00899-7","url":null,"abstract":"<p><p>Gastrointestinal stromal tumor (GIST) is the most common mesenchymal neoplasm of the digestive tract; however, cases originating from the small intestine that present as a pelvic adnexal mass with prominent calcification and ossification are extremely rare. Here we report a 55-year-old female patient who was found to have a pelvic mass during a routine health examination. Preoperative imaging revealed a hypervascular lesion with ossification in the right adnexal region, initially suspicious for an ovarian neoplasm. Retrospective analysis of the imaging data revealed that the tumor's feeding vessels originated from branches of the superior mesenteric artery rather than the ovarian artery, and despite its pelvic location, the tumor did not cause significant compression on adjacent organs such as the bladder, suggesting it might be an intestinal-derived dropping mass. Pathology confirmed a small intestine-originated GIST (mixed spindle cell and epithelioid type) with extensive calcification and ossification within the tumor. Immunohistochemistry showed positivity for CD117 and DOG1, and molecular testing identified a <i>KIT</i> gene exon 11 mutation c.1676T > A (p.V559D). The postoperative risk classification was low risk. This case underscores that for a calcified/ossified pelvic mass, the possibility of an intestinal GIST dropping into the pelvis should be strongly considered, and attention should be paid to the vascular origin features on imaging and the analysis of tumor mobility.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"15 4","pages":"587-593"},"PeriodicalIF":0.4,"publicationDate":"2026-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13598046/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149038474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Spontaneous regression and subsequent metachronous development of dedifferentiated liposarcoma: a case report.","authors":"Kunihiro Ikuta, Masato Nakaguro, Hiroshi Urakawa, Tomohisa Sakai, Hiroshi Koike, Takeo Fujito, Murase Fuminori, Harumi Nakamura, Seiji Nakamura, Takayuki Nojima, Kennosuke Karube, Shiro Imagama","doi":"10.1007/s13691-026-00898-8","DOIUrl":"10.1007/s13691-026-00898-8","url":null,"abstract":"<p><p>Dedifferentiated liposarcoma (DDLPS) is a high-grade liposarcoma, and spontaneous regression of the primary tumor is extremely uncommon. We describe a patient with primary DDLPS of the lower abdominal wall that regressed without treatment and subsequently developed a second DDLPS at a different site. A 66-year-old man presented with a painful mass in the left lower abdomen. MRI demonstrated an infiltrative soft tissue tumor without a definite fatty component. Repeated biopsies showed spindle cell proliferation with inflammatory myofibroblastic features, and <i>MDM2</i> amplification was confirmed by fluorescence in situ hybridization, leading to the diagnosis of DDLPS. Although wide resection was planned, the tumor gradually decreased in size after biopsy and almost completely disappeared during follow-up. Nine years later, a new tumor developed in the right lower abdominal wall. Wide resection was performed, and pathological examination demonstrated high-grade DDLPS with adjacent well-differentiated liposarcoma component. Review of the imaging and pathological findings suggested that the initial lesion had undergone spontaneous regression and that the second lesion represented metachronous dedifferentiation arising in a background of well-differentiated liposarcoma. This case illustrates an unusual clinical course of DDLPS. These findings suggest that spontaneous regression of the dedifferentiated component may occur and that metachronous dedifferentiation can subsequently develop at a different site during long-term follow-up.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"15 4","pages":"594-600"},"PeriodicalIF":0.4,"publicationDate":"2026-08-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13597968/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149038459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Preoperative cine MRI assessment of suspected hepatic invasion by a large abdominal wall dermatofibrosarcoma protuberans: a case report.","authors":"Chiaki Sato, Jungo Imanishi, Kenji Sato, Yoshinao Kikuchi, Asako Yamamoto","doi":"10.1007/s13691-026-00897-9","DOIUrl":"10.1007/s13691-026-00897-9","url":null,"abstract":"<p><p>Dermatofibrosarcoma protuberans (DFSP) is a locally aggressive soft-tissue tumor which requires wide surgical resection. Therefore, assessment of adjacent organ invasion is crucial for surgical planning. Cine magnetic resonance imaging (cine MRI) is a technique for dynamic evaluation of organ motion and has demonstrated a clear diagnostic value in determining the absence of tumor adhesion or invasion in previously reported cases of various malignancies. We report the case of a woman in her 50s with a 20-cm anterior abdominal wall DFSP. Preoperative contrast-enhanced computed tomography and conventional MRI sequences identified no intervening fat plane between the tumor and the liver, indicating potentially extensive contact with segment IV of the liver and making definitive exclusion of hepatic invasion difficult. To assess tumor mobility, cine MRI was performed using a T2-weighted single-shot fast spin echo sequence combined with deep learning-based reconstruction during deep respiration. Cine MRI showed residual respiratory-dependent sliding motion between the tumor and the liver, supporting the absence of hepatic invasion. Based on this finding, the surgical plan was modified to avoid unnecessary partial hepatectomy. Surgical and histopathological findings confirmed the absence of hepatic invasion. This case suggests that assessment of sliding motion on cine MRI may support informed surgical planning when adjacent organ invasion is suspected in soft-tissue sarcomas.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at https://doi.org/10.1007/s13691-026-00897-9.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"15 4","pages":"550-555"},"PeriodicalIF":0.4,"publicationDate":"2026-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13598016/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149038515","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Murat Haskul, Mustafa Dikilitas, Serhat Toprak, Ümran Gemici, Muhammed Furkan Keser
{"title":"Rectal cancer with intraluminal metastasis to the duodenum.","authors":"Murat Haskul, Mustafa Dikilitas, Serhat Toprak, Ümran Gemici, Muhammed Furkan Keser","doi":"10.1007/s13691-026-00896-w","DOIUrl":"10.1007/s13691-026-00896-w","url":null,"abstract":"<p><p>This study aims to present the diagnosis, treatment process, and clinical course of a patient with advanced rectal adenocarcinoma presenting with rare duodenal metastases. A 47-year-old male patient presented with constipation. A mass obstructing the entire lumen was detected in the rectosigmoid region, and the biopsy result was reported as rectal adenocarcinoma. Clinical staging was determined as T4aN2bM0. Due to the obstruction, a loop sigmoidostomy was performed, and Total Neoadjuvant Therapy (TNT) was planned. Within the scope of TNT, 5- Fluorouracil (5-FU), Oxaliplatin, Capecitabine, and 25 fractions of radiotherapy were administered. Surgically, Low Anterior Resection (LAR) was performed, and pathology confirmed pT4N2, with the presence of lymphovascular and perineural invasion. In the fifth postoperative month, preaortic and paraaortic lymphadenopathy was detected; a KRAS mutation was identified. Partial regression was observed in the lymph nodes following the new chemotherapy regimen (5-FU +Irinotecan+Bevacizumab), but cholestasis developed. Imaging and Endoscopic Retrograde Cholangiopancreatography (ERCP) revealed ulcerative metastatic masses in the duodenum and ampulla of Vater regions. Biopsy results and immunohistochemical analyses (CDX2, SATB2, Beta-Catenin) confirmed colon adenocarcinoma metastasis. Next-generation sequencing (NGS) analysis showed a recurrent KRAS mutation, stable microsatellite stability(MSI), and intact Mismatch Repair (MMR). Although symptomatic relief was achieved with biliary drainage and a duodenal stent, advanced metastases (liver, adrenal, bone) developed. Duodenal metastasis in patients with rectal adenocarcinoma is rare but clinically severe and has a poor prognosis. This case demonstrates the rare metastatic pathways of advanced colorectal cancer, management challenges, and palliative treatment strategies. Keywords: Rectal cancer; Duodenal metastasis; Intraluminal metastasis; KRAS mutation; Colorectal cancer.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"15 4","pages":"544-549"},"PeriodicalIF":0.4,"publicationDate":"2026-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13598043/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149038448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Prolongation of prothrombin time-international normalized ratio in a patient receiving warfarin and gemcitabine: a case report.","authors":"Yuki Kawarada, Masayuki Miyazaki, Ayako Mitsuma, Yuichi Ando, Hiroaki Ikesue","doi":"10.1007/s13691-026-00891-1","DOIUrl":"10.1007/s13691-026-00891-1","url":null,"abstract":"<p><p>Potential interactions between gemcitabine and warfarin have been described in case reports. However, it has been argued that the available data are insufficient to support this interaction due to the limited number of cases. We present the case of a patient who developed prolongation of prothrombin time/international normalized ratio (PT/INR) following gemcitabine administration while receiving warfarin. The patient was a 58-year-old man with Marfan syndrome who had been receiving warfarin for 30 years, usually at a dose of 8-10 mg. He was diagnosed with primary testicular leiomyosarcoma and subsequently experienced a relapse of pulmonary metastases following orchiectomy. After an inadequate response to doxorubicin, combination therapy with gemcitabine and docetaxel (intravenous gemcitabine 900 mg/m<sup>2</sup> on days 1 and 8 and intravenous docetaxel 75 mg/m<sup>2</sup> on day 8 every 3 weeks) was initiated as second-line treatment. At the start of this combination therapy, the patient was receiving a daily warfarin dose of 10 mg. Following initiation of gemcitabine, two consecutive episodes of INR prolongations were observed 2 days after each administration. The INR increased from 2.04 to 2.44 on day 36 and from 1.87 to 2.66 on day 43, accompanied by Grade 2 elevation in aspartate aminotransferase and alanine aminotransferase levels. Total bilirubin remained within normal limits. His daily warfarin dose was reduced and maintained at 6.0 mg, resulting in INR values ranging between 2.0 and 2.5. Although the precise mechanism remains unclear, gemcitabine-induced hepatic dysfunction may have contributed to the enhanced anticoagulant effect of warfarin. Given the potential for early INR elevation, close INR monitoring during the initial phase of gemcitabine therapy may be warranted in patients receiving concomitant warfarin.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"15 4","pages":"529-533"},"PeriodicalIF":0.4,"publicationDate":"2026-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13597998/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149038530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Shivali Maurya, Md Ali Osama, Rajni Yadav, Ankita Singh
{"title":"Hidden malignancy in an ileal duplication cyst: a rare adult case highlighting the practical challenges.","authors":"Shivali Maurya, Md Ali Osama, Rajni Yadav, Ankita Singh","doi":"10.1007/s13691-026-00889-9","DOIUrl":"10.1007/s13691-026-00889-9","url":null,"abstract":"<p><p>Malignant transformation within an intestinal duplication cyst is uncommon and rarely detected preoperatively. Here, we report a 28-year-old man who presented with vomiting along with a progressively enlarging abdominal lump and weight loss. Imaging revealed a large cystic intra-abdominal lesion with a mural solid component and focal calcifications, but the diagnosis remained uncertain. Surgical excision was performed, and histopathological examination demonstrated a moderately differentiated adenocarcinoma arising within a non-communicating ileal duplication cyst. The patient remained clinically stable without evidence of recurrence at the six-month follow-up. This case highlights the diagnostic limitations of imaging and emphasizes the importance of complete excision and meticulous histopathological examination of adult duplication cysts, particularly when mural nodularity or other suspicious features are present.</p>","PeriodicalId":13703,"journal":{"name":"International Cancer Conference Journal","volume":"15 4","pages":"538-543"},"PeriodicalIF":0.4,"publicationDate":"2026-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13597983/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149038501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}